Cells,
Journal Year:
2024,
Volume and Issue:
13(2), P. 161 - 161
Published: Jan. 16, 2024
P2X
receptors
are
a
family
of
seven
ATP-gated
ion
channels
that
trigger
physiological
and
pathophysiological
responses
in
variety
cells.
Five
the
members
sensitive
to
low
concentrations
extracellular
ATP,
while
P2X6
receptor
has
an
unknown
affinity.
The
last
subtype,
P2X7
receptor,
is
unique
requiring
millimolar
fully
activate
humans.
This
sensitivity
imparts
agonist
with
ability
act
as
damage-associated
molecular
pattern
triggers
innate
immune
response
elevated
levels
ATP
accompany
inflammation
tissue
damage.
In
this
review,
we
focus
on
microglia
because
they
primary
cells
central
nervous
system,
or
its
synthetic
analog,
BzATP.
We
start
by
introducing
purinergic
then
briefly
consider
roles
play
neurodevelopment
disease
referencing
both
original
works
relevant
reviews.
Next,
move
role
initiating
and/or
modulating
immunity
system.
While
most
data
review
involve
work
mice
rats,
highlight
human
studies
P2X7R
whenever
possible.
Cells,
Journal Year:
2020,
Volume and Issue:
9(11), P. 2496 - 2496
Published: Nov. 17, 2020
Adenosine
triphosphate
(ATP)
is
one
of
the
main
biochemical
components
tumor
microenvironment
(TME),
where
it
can
promote
progression
or
suppression
depending
on
its
concentration
and
specific
ecto-nucleotidases
receptors
expressed
by
immune
cancer
cells.
ATP
be
released
from
cells
via
both
nonspecific
pathways.
A
non-regulated
release
occurs
dying
damaged
cells,
whereas
active
involves
exocytotic
granules,
plasma
membrane-derived
microvesicles,
ATP-binding
cassette
(ABC)
transporters
membrane
channels
(connexin
hemichannels,
pannexin
1
(PANX1),
calcium
homeostasis
modulator
(CALHM1),
volume-regulated
anion
(VRACs)
maxi-anion
(MACs)).
Extracellular
acts
at
P2
purinergic
receptors,
among
which
P2X7R
a
key
mediator
final
ATP-dependent
biological
effects.
Over
years,
receptor-
ecto-nucleotidase-targeting
for
therapy
has
been
proposed
actively
investigated,
while
comparatively
fewer
studies
have
explored
suitability
TME
as
target.
In
this
review,
we
briefly
summarize
available
evidence
suggesting
that
central
role
in
determining
fate
is,
therefore,
suitable
target
therapy.
AJP Cell Physiology,
Journal Year:
2020,
Volume and Issue:
318(5), P. C832 - C835
Published: March 11, 2020
Danger
sensing
is
one
of
the
most
fundamental
evolutionary
features
enabling
multicellular
organisms
to
perceive
potential
threats,
escape
from
risky
situations,
fight
actual
intruders,
and
repair
damage.
Several
endogenous
molecules
are
used
"signal
damage,"
currently
referred
as
"alarmins"
or
"damage-associated
molecular
patterns"
(DAMPs),
being
already
present
within
all
cells
(preformed
DAMPs),
thus
ready
be
released,
others
neosynthesized
following
injury.
Over
recent
years
it
has
become
overwhelmingly
clear
that
adenosine
5'-triphosphate
(ATP)
a
ubiquitous
extremely
efficient
DAMP
(thus
promoting
inflammation),
its
main
metabolite,
adenosine,
strong
immunosuppressant
dampening
inflammation).
Extracellular
ATP
ligates
activates
P2
purinergic
receptors
(P2Rs)
then
degraded
by
soluble
plasma
membrane
ecto-nucleotidases
generate
acting
at
P1
(P1Rs).
ATP,
P2Rs,
ecto-nucleotidases,
P1Rs
basic
elements
signaling
network
pillars
inflammation.
Journal of Hematology & Oncology,
Journal Year:
2022,
Volume and Issue:
15(1)
Published: April 27, 2022
Abstract
Targeting
nucleotide
metabolism
can
not
only
inhibit
tumor
initiation
and
progression
but
also
exert
serious
side
effects.
With
in-depth
studies
of
metabolism,
our
understanding
in
tumors
has
revealed
their
non-proliferative
effects
on
immune
escape,
indicating
the
potential
effectiveness
antimetabolites
for
enhancing
immunotherapy.
A
growing
body
evidence
now
supports
concept
that
targeting
increase
antitumor
response
by
(1)
activating
host
systems
via
maintaining
concentrations
several
important
metabolites,
such
as
adenosine
ATP,
(2)
promoting
immunogenicity
caused
increased
mutability
genomic
instability
disrupting
purine
pyrimidine
pool,
(3)
releasing
nucleoside
analogs
microbes
to
regulate
immunity.
Therapeutic
approaches
combined
with
immunotherapy
have
achieved
exciting
success
preclinical
animal
models.
Here,
we
review
how
dysregulated
promote
growth
interact
system,
provide
future
insights
into
immunotherapeutic
treatment
various
malignancies.
Cell Death and Disease,
Journal Year:
2022,
Volume and Issue:
13(4)
Published: April 12, 2022
Abstract
Retinal
endothelial
cells
(RECs)
are
the
primary
target
for
diabetes-induced
vascular
damage.
The
P2X7/NLRP3
pathway
plays
an
essential
role
in
amplifying
inflammation
via
ATP
feedback
loop,
promoting
inflammatory
response,
pyroptosis,
and
apoptosis
of
RECs
early
stages
diabetic
retinopathy
induced
by
hyperglycemia
inflammation.
3TC,
a
type
nucleoside
reverse
transcriptase
inhibitor,
is
effective
against
inflammation,
as
it
can
targeting
formation
P2X7
large
pore
formation.
Hence,
our
aim
was
to
evaluated
anti-inflammatory
effects
potential
mechanisms
action
3TC
vitro
retinal
microvascular
treated
with
high-glucose
(HG)
lipopolysaccharide
(LPS),
well
vivo
retinas
C57BL/6J
male
mice
streptozotocin-induced
diabetes.
expression
inflammasome-related
proteins
NLRP3,
3TC-treated
were
compared
those
untreated
mice.
Furthermore,
anti-inflammatory,
anti-apoptotic,
anti-pyroptotic
cultured
cells.
Co-application
HG
LPS
significantly
increased
secretion
IL-6,
IL-1β,
TNF-α,
levels,
whereas
decreased
cell
apoptosis,
pyroptosis.
Inhibition
P2X7R
NLRP3
inflammasome
activation
inflammasome-mediated
injury.
prevented
cytokine
release
following
co-application
LPS/BzATP.
Our
findings
provide
new
insights
regarding
environment-induced
injury,
including
Nature Cancer,
Journal Year:
2024,
Volume and Issue:
5(8), P. 1206 - 1226
Published: June 6, 2024
Many
individuals
with
cancer
are
resistant
to
immunotherapies.
Here,
we
identify
the
gene
encoding
pyrimidine
salvage
pathway
enzyme
cytidine
deaminase
(CDA)
among
top
upregulated
metabolic
genes
in
several
immunotherapy-resistant
tumors.
We
show
that
CDA
cells
contributes
uridine
diphosphate
(UDP)
pool.
Extracellular
UDP
hijacks
immunosuppressive
tumor-associated
macrophages
(TAMs)
through
its
receptor
P2Y
Physiological Reviews,
Journal Year:
2020,
Volume and Issue:
100(4), P. 1621 - 1705
Published: March 19, 2020
The
urothelium,
which
lines
the
renal
pelvis,
ureters,
urinary
bladder,
and
proximal
urethra,
forms
a
high-resistance
but
adaptable
barrier
that
surveils
its
mechanochemical
environment
communicates
changes
to
underlying
tissues
including
afferent
nerve
fibers
smooth
muscle.
goal
of
this
review
is
summarize
new
insights
into
urothelial
biology
function
have
occurred
in
past
decade.
After
familiarizing
reader
with
key
aspects
histology,
we
describe
development
regeneration.
This
followed
by
an
extended
discussion
function,
information
about
roles
glycocalyx,
ion
water
transport,
tight
junctions,
cellular
tissue
shape
other
adaptations
accompany
expansion
contraction
lower
tract.
We
also
explore
evidence
urothelium
can
alter
solute
composition
urine
during
normal
physiology
response
overdistension.
complete
providing
overview
our
current
knowledge
environment,
discussing
sensor
transducer
functions
exploring
role
circadian
rhythms
gene
expression,
describing
novel
research
tools
are
likely
further
advance
understanding
biology.
Cancers,
Journal Year:
2022,
Volume and Issue:
14(5), P. 1116 - 1116
Published: Feb. 22, 2022
The
purinergic
P2X7
receptor
(P2X7R)
is
a
transmembrane
protein
whose
expression
has
been
related
to
variety
of
cellular
processes,
while
its
dysregulation
linked
inflammation
and
cancer.
P2X7R
expressed
in
cancer
immune
system
cell
surfaces.
ATP
plays
key
role
numerous
metabolic
processes
due
abundance
the
tumour
microenvironment.
an
important
by
interacting
with
ATP.
unusual
property
that
stimulation
low
doses
causes
opening
permeable
channel
for
sodium,
potassium,
calcium
ions,
whereas
sustained
high
favours
formation
non-selective
pore.
latter
effect
induces
change
intracellular
homeostasis
leads
death.
This
evidence
suggests
both
pro-
anti-tumour
proprieties.
increasingly
recognised
as
regulator
inflammation.
In
this
review,
we
aimed
describe
most
relevant
characteristics
function,
activation,
ligands,
also
summarising
activation
context
currently
used
therapeutic
approaches
clinical
trials
modulators
are
described.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research,
Journal Year:
2022,
Volume and Issue:
1869(5), P. 119237 - 119237
Published: Feb. 9, 2022
Nucleotides
are
released
from
all
cells
through
regulated
pathways
or
as
a
result
of
plasma
membrane
damage
cell
death.
Outside
the
cell,
nucleotides
act
signalling
molecules
triggering
multiple
responses
via
specific
receptors
P2
family.
In
nervous
system,
purinergic
has
key
function
in
neurotransmission.
is
one
major
modulators
basal
tissue
homeostasis,
while
its
dysregulation
contributes
to
pathogenesis
various
disease,
including
inflammation
and
cancer.
Pre-clinical
clinical
evidence
shows
that
selective
agonists
antagonists
effective
treatments
for
many
pathologies,
thus
highlighting
relevance
extracellular
therapeutic
targets.